Phibro Animal Health Corporation (PAHC) financial statements and ratios from SEC XBRL: revenue $1.5B (TTM), net margin 3.7%, revenue growth 10.3% YoY, P/E 15.6. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $1.30B |
| Revenue (TTM) | $1.5B |
| Net Margin | 3.7% |
| Operating Margin (TTM) | 12.0% |
| Net Debt / EBITDA | 2.5 |
| Revenue Growth (YoY) | 10.3% |
| EPS Growth (YoY) | 13.5% |
| FCF Growth (YoY) | -97.5% |
| P/E Ratio | 15.6 |
| EV / EBITDA | 8.9 |
| Price / Book | 4.12 |
| Price / Sales | 0.99 |
| FCF Yield | 0.9% |
| Altman Z-Score | 2.78 (grey) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
PAHC overview · PAHC earnings · PAHC KPIs · PAHC documents · PAHC ownership · PAHC peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.